Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline Post Exposure Prophylaxis to Prevent Incident Bacterial STIs Among Women in the United States
NCT07704957Phase 4Not yet recruiting
- Sponsor
- Tulane University
- Start
- Jan 2027
- Primary completion
- Feb 2031
01
Overview
Phase 4, randomised, open-label trial of doxycycline in Chlamydia trachomatis infection (CT), gonorrhea and syphilis (2 arms), sponsored by Tulane University. Primary endpoint: chlamydia incidence. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
doxycycline
03
Conditions
Chlamydia trachomatis infection (CT)gonorrheasyphilis
Beyond the preview
Go deeper on NCT07704957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07704957.